The immediate aim of MicroC is to develop computational methods that allow us to better understand, and hopefully overcome, drug resistance in a particularly tough cancer, the triple-negative breast cancer. The ultimate goal is to generalize the approach and to unveil cellular behavior and interactions in a variety of complex diseases and environments, i.e. where different types of cells signal each other following different biological pathways.